Merck's molnupiravir has been used in Israel and other countries since late 2021 to treat symptomatic patients with risk factors that could lead to hospitalization or death

Researchers at Weizmann Institute studying mice identify genetic mutation as potential biomarker for successful treatment with existing drug

Shaare Zedek Medical Center participates in international long-term clinical trial of Denosumab, which investigators say may offer medical alternative to preventive mastectomy

Each new infection gives the virus a chance to mutate as it makes copies of itself, threatening to undo the progress made so far to control the pandemic

Culling all of its 15-17 million minks, country's health ministry says no case of mutated strain has been detected since September 15